Studies investigating activity and expression of carbonic anhydrases in cardiovascular disease have found elevated CA1 and CA2 expression in diabetic ischemic cardiomyopathy (28) as well as elevated expression of CA2 and CA4 in patients with hypertrophic hearts (29). Here, CA2 is linked to cardiovascular disorder.